Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Lifebit
Genomics and real-world data platform
Health data & AI platforms
London-based federated genomics and real-world data platform that lets pharma R&D teams analyse sensitive datasets in place, without moving the underlying data.
The read
Lifebit operates a federated Trusted Research Environment that lets pharma, biotech and government health bodies analyse sensitive genomic and multi-omic data in place, rather than centralising it, aimed at speeding up drug target validation and biomarker discovery.
Its Genomics England relationship and long-term Boehringer Ingelheim AI partnership are among its most independently corroborated deployments, alongside government-scale work with Singapore's national health data agency Synapxe.
The Bridgehead view
Lifebit's federated-analysis pitch, letting pharma R&D touch data it's not allowed to move, solves a real procurement blocker rather than a nice-to-have, which is why its pharma partnerships have stuck longer than most funding-round headlines in this category.
Work with us
Working across the healthcare sector?
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
Related platforms
Others in the sector map
Trusted research environment
Aridhia
Glasgow-based trusted research environment platform letting hospitals, universities and life-sciences researchers securely analyse sensitive health data without moving it off a governed environment.
ReadHuman genetics data science for drug discovery
Genomics
Oxford-based data science company applying human genetics and polygenic risk scoring to drug discovery, insurance underwriting and precision health.
ReadThe firm that knows medtech
We map this sector because
we represent it.
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.
